Course : ACMG Genomics Case Conferences- November 2014- May 2015
A compilation of seven Genomic Case Conferences that took place from November 2014-2015.
Click “Launch” for details.
11/19/2014 Clinical Exome Sequencing Solving Medical Mysteries
Hosted by Baylor Medical Center
12/17/2014 Ending Diagnostic Odysseys: Clinical and Research Experiences with Genomic Sequencing
Hosted by Partners Healthcare
1/21/2015 Detecting Complex Disease Mechanisms and Unusual Disease Presentation Using Whole Exome Sequencing
Hosted by GeneDx
2/18/2015 Cardio, Coags, Cancer, Oh my! Factors that Impact Whether to Report Secondary, Medically?actionable Findings
Hosted by The University of North Carolina at Chapel Hill
3/18/2015 Genomic Data Boards: A New Model for Clinical Exome Sequencing Variant Interpretation
Hosted by the David Geffen School of Medicine at UCLA
4/15/2015 Family Centered Diagnostic Exome Sequencing Solved Undiagnosed Cases: Detection, Analysis, and Interpretation of Characterized and Novel Genetic Etiologies
Hosted by Ambry Genetics
5/20/2015 Whole Exome Sequencing in Disorders of Sex Development
Hosted by Albert Einstein College of Medicine
A team from select institutions will present and lead discussions on intriguing, complex or difficult patient cases in the area of genomics that makeup ACMG Genomics Case Conferences. "This is the first monthly internet-based live case conference in genomics in the US. As ACMG continues to provide new and innovative approaches to education in genetic medicine, we are excited to add this to our list of webinars, videos, in-person conferences, point-of-care tools like the ACT Sheets mobile app, and more," said Michael S. Watson, MS, PhD, FACMG, executive director of the ACMG.
A main focus of these case conferences will be on the adaptation of exome or genome sequencing technology in clinical care.
This activity is supported by an unrestricted educational grant from QIAGEN Bioinformatics and the Ingenuity Clinical Decision Support Platform.
Course Information - Click here for details
Educational Credits Available
Amount of Credits: 7
ACMG Members and ACMG Trainees free
ACMG Member with educational credits ($15)
Non-members with educational credits ($55)
At the conclusion of the series, participants should be able to:
1. Describe the clinical utility of whole exome/whole genome sequencing tests
2. Identify clinical indications for whole exome/whole genome sequencing
3. List determinants used to assess the probability of a variant’s pathogenicity
4. Elaborate on the importance of pre-test counseling and consent
5. Discuss the meaning of “secondary findings” in whole exome/whole genome sequencing tests